哈药股份所属企业药品通过一致性评价

Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. (哈药股份) announced that its subsidiary, Harbin Pharmaceutical Group Pharmaceutical Factory (哈药总厂), received approval from the National Medical Products Administration for two formulations of injectable cefoperazone sodium and sulbactam sodium, indicating successful completion of the consistency evaluation for generic drug quality and efficacy [1] Group 1 - The company received approval for two formulations: injectable cefoperazone sodium and sulbactam sodium in two ratios (1:1 and 2:1) [1] - A total of four specifications for these drugs have passed the consistency evaluation [1]